MHLA:NYE-Maiden Holdings Ltd. 6.625% Notes due 2046 (USD)

EQUITY | Insurance | New York Stock Exchange

Last Closing

USD 15.5

Change

+0.21 (+1.37)%

Market Cap

USD 1.30B

Volume

1.76K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Insurance

Symbol Name Price(Change) Market Cap
AFGE American Financial Group AFGE

-0.02 (-0.10%)

USD 9.87B

ETFs Containing MHLA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.52% 50% F 15% F
Dividend Return 2.47% 100% F 81% B-
Total Return -5.05% 50% F 17% F
Trailing 12 Months  
Capital Gain -0.45% 50% F 26% F
Dividend Return 5.32% 50% F 71% C-
Total Return 4.87% 50% F 30% F
Trailing 5 Years  
Capital Gain 3.26% 100% F 44% F
Dividend Return 19.31% 100% F 70% C-
Total Return 22.57% 100% F 46% F
Average Annual (5 Year Horizon)  
Capital Gain -0.63% 100% F 36% F
Dividend Return 2.51% 100% F 39% F
Total Return 3.14% 50% F 62% D
Risk Return Profile  
Volatility (Standard Deviation) 19.13% 50% F 58% F
Risk Adjusted Return 13.13% 100% F 36% F
Market Capitalization 1.30B 50% F 58% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Insurance) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio -99,999.99 100% 100%
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio -21.82 100% 95%
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital -5.69% 50% 14%
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.